ClinicalTrials.gg
RecruitingNCT07466069Updated Mar 12, 2026

Lifestyle Intervention for Obesity and Eating Disorder Prevention in Transgender Adolescents

An interventional study of TransForm Health Program in Obesity & Overweight, Eating Disorders and Body Image Disturbance, sponsored by University of Sao Paulo. Recruiting at 1 site in Brazil. Open to participants aged 10 Years to 14 Years. Per ClinicalTrials.gov, last updated 2026-03-12.

Sponsored by University of Sao Paulo · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
10 Years to 14 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 42 studies in Obesity by University of Sao Paulo — 5 open to participants now, 11 under way, none of them phase 3. Obesity · University of Sao Paulo.

Planned enrollment
28th of 35
24 · median 40
Started
2026
with 3 others
No phase
30 of 42
5 open now
Primary completion
2026-12
later than 7 of 10 live
Registered
39th of 42
by date

Among the 42 studies in Obesity by University of Sao Paulo, this one is the 28th largest by planned enrollment of the 35 interventional ones that give a count, is one of 4 that started in 2026, is one of 30 with no phase, reaches primary completion later than 7 of the 10 other live ones, and was the 39th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

5 of the 42 studies in Obesity by University of Sao Paulo are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 10 Years to 14 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 42 studies in Obesity by University of Sao Paulo, or all of them as a file.
02

Study summary

Transgender and gender-diverse adolescents are at increased risk for obesity, disordered eating behaviors, body dissatisfaction, and reduced quality of life due to minority stress and structural inequities. However, no structured lifestyle interventions specifically tailored to this population have been developed.

This randomized controlled trial aims to evaluate the effectiveness of a 6-month interdisciplinary lifestyle intervention designed to prevent obesity and eating disorders in transgender and gender-diverse adolescents aged 10-14 years. Participants will be randomized (1:1) to either an intervention group receiving monthly group sessions (for adolescents and caregivers separately) and weekly supportive messages, or a control group receiving standard outpatient care and general health recommendations.

The primary outcome is quality of life measured by the WHOQOL-BREF. Secondary outcomes include eating disorder symptoms, body image, diet quality, physical activity levels, sedentary behavior, body composition, and anthropometric measures.

Read the detailed description

This study is a parallel-group randomized controlled trial conducted at the Lifestyle Medicine Center, Faculty of Medicine, University of São Paulo (FMUSP), Brazil.

Participants will be recruited from the Gender Identity and Sexual Orientation Outpatient Clinic (AMTIGOS) at the Institute of Psychiatry, Hospital das Clínicas, University of São Paulo. Eligible transgender and gender-diverse adolescents aged 10 to 14 years receiving care at AMTIGOS will be invited to participate.

After baseline assessments, participants will be randomly assigned (1:1), in blocks of six, to either:

  1. an interdisciplinary lifestyle intervention plus usual outpatient care; or
  2. usual outpatient care plus a single session of general health recommendations.

The 6-month intervention is grounded in Social Cognitive Theory and incorporates gender-affirmative principles and an intersectional framework. The intervention includes:

  • Monthly group sessions for adolescents
  • Monthly educational group sessions for caregivers
  • Weekly reinforcement messages

The program focuses on promoting healthy eating behaviors, increasing physical activity, reducing sedentary behavior, preventing unhealthy weight-control practices, and fostering positive body image and body appreciation.

The control group will receive standard outpatient follow-up at AMTIGOS and a single individual session including general recommendations regarding healthy eating, physical activity, body acceptance, and avoidance of unhealthy weight-control behaviors.

Outcomes will be assessed at baseline and after 6 months. The primary outcome is quality of life measured by the WHOQOL-BREF. Secondary outcomes include eating disorder symptoms, body image, dietary quality, physical activity, sedentary behavior, body composition, and anthropometric measures.

03

Conditions studied

  • Obesity & Overweight
  • Eating Disorders
  • Body Image Disturbance
  • Gender Diverse Populations

Keywords

  • Transgender
  • Adolescent
  • Gender-diverse
  • Lifestyle
  • Eating disorders
  • Obesity
04

Who can participate

Ages eligible
10 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 10-14 years
  • Self-identified as transgender or gender-diverse

Exclusion criteria

Exclusion Criteria:

  • Current diagnosis of eating disorder requiring specialized treatment
  • Severe psychiatric instability
  • Cognitive impairment limiting participation
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    TransForm Health group

    A group intervention focused on promoting health lifestyle behaviors for preventing obesity and eating disorders in transgender and gender-diverse adolescents.

    Behavioral: TransForm Health Program

  • No intervention
    Control group

    Usual care and general health lifestyle behaviors recommendations.

Interventions

  • BehavioralTransForm Health Program

    A 6-month structured intervention including monthly adolescent group sessions, monthly caregiver sessions, monthly individual goal-setting meetings, and weekly reinforcement messages focused on healthy eating, physical activity, body appreciation, and prevention of unhealthy weight-control behaviors.

06

What researchers measure

Primary outcomes

  1. Quality of Life (World Health Organization Quality of Life - BREF)

    Quality of life will be measured using the World Health Organization Quality of Life - BREF (WHOQOL-BREF) questionnaire. The WHOQOL-BREF consists of 26 items covering four domains (physical health, psychological health, social relationships, and environment). Domain scores are transformed to a scale ranging from 0 to 100, with higher scores indicating better quality of life.

    Time frame: Baseline and 6 months

Secondary outcomes

  1. Body fat

    Body fat will be measured by dual-energy X-ray absorptiometry (DEXA).

    Time frame: Baseline and 6 months

  2. Muscle mass

    Muscle mass will be measured by dual-energy X-ray absorptiometry (DEXA).

    Time frame: Baseline and 6 months

  3. Bone density

    Bone density will be measured by dual-energy X-ray absorptiometry (DEXA).

    Time frame: Baseline and 6 months

  4. Body mass index (BMI)

    BMI Z-score will be assessed by weight (kg) and height (m) that will be combined to report BMI in kg/m\^2 Z-score according to the World Health Organization growth curves.

    Time frame: Baseline and 6 months

  5. Food consumption

    Food consumption will be assessed by three 24h food records.

    Time frame: Baseline and 6 months

  6. Food insecurity

    Food insecurity will be assessed using the Brazilian Food Insecurity Scale (EBIA), a 14-item questionnaire assessing household access to food in the previous 90 days. The total score ranges from 0 to 14, with higher scores indicating greater food insecurity.

    Time frame: Baseline and 6 months

  7. Diet quality (Diet Quality Scale - ESQUADA)

    Diet quality will be assessed using the Diet Quality Scale (ESQUADA - Escala de Qualidade da Dieta), a questionnaire based on the Brazilian Dietary Guidelines. The total score ranges from 0 to 100, with higher scores indicating better diet quality.

    Time frame: Baseline and 6 months

  8. Diet quality (Health Eating Index-2020)

    Diet quality will also be assessed using the Healthy Eating Index-2020 (HEI-2020), a measure of adherence to the Dietary Guidelines for Americans. The total score ranges from 0 to 100, with higher scores indicating better diet quality.

    Time frame: Baseline and 6 months

  9. Food choice motives

    Determinants of food choice will be assessed using the Eating Motivation Survey - Brief Version (TEMS), a questionnaire assessing motivations underlying food choices across multiple domains. Items are rated on a 5-point Likert scale ranging from 1 to 5, with higher scores indicating stronger endorsement of the respective eating motivation.

    Time frame: Baseline and 6 months

  10. Screening for eating disorders

    Screening for eating disorders will be conducted using the SCOFF questionnaire, a 5-item screening tool with yes/no responses. Scores range from 0 to 5, with higher scores indicating greater likelihood of an eating disorder. A score of 2 or more positive responses suggests a possible eating disorder and indicates the need for further assessment.

    Time frame: Baseline and 6 months

  11. Eating disorders symptoms

    Eating disorder symptoms will be assessed using the Eating Disorder Examination Questionnaire (EDE-Q), a 28-item self-report instrument assessing eating disorder psychopathology over the previous 28 days. Items are rated on a 7-point scale ranging from 0 to 6, with higher scores indicating greater eating disorder psychopathology. The global score ranges from 0 to 6, representing the mean of four subscale scores

    Time frame: Baseline and 6 months

  12. Body image dissatisfaction

    Body dissatisfaction will be assessed using the Body Shape Questionnaire (BSQ), a 34-item questionnaire measuring concerns about body shape. Items are rated on a 6-point Likert scale, with total scores ranging from 34 to 204, where higher scores indicate greater body dissatisfaction.

    Time frame: Baseline and 6 months.

  13. Body image appreciation

    Body image apprciation will be assessed using the Body Appreciation Scale-2 (BAS-2), a 10-item questionnaire evaluating body appreciation and respect for one's body. Items are rated on a 5-point Likert scale, with total scores ranging from 10 to 50, where higher scores indicate greater body appreciation.

    Time frame: Baseline and 6 months.

  14. Physical activity level and sedentary behavior

    Physical activity and sedentary behavior will be assessed using the Physical Activity Questionnaire from the 2015 follow-up of the 1993 Pelotas Birth Cohort, which includes questions on leisure-time physical activity, active transportation, screen time, and sedentary behavior. Outcomes will be reported as time spent in physical activity and sedentary behaviors (minutes per week or hours per day), with higher physical activity indicating healthier behavior and higher sedentary time indicating less favorable behavior.

    Time frame: Baseline and 6 months

  15. Participant's perception of the intervention

    Participants' perceptions of the intervention will be assessed through post-intervention semi-structured focus groups. Audio-recorded discussions will be transcribed and analyzed using thematic qualitative analysis to identify key themes related to participants' experiences, perceived benefits, and challenges of the intervention.

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The results produced will be shared as requested by participants. All those who wish to be included will be included in a specific category in publications where this is possible.

Supporting information: Study protocol, Informed consent form, Clinical study report

Time frame: After the analysis is completed

Access criteria: Having been a participant in the RCT

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2026; primary completion for Dec 2026, 9 months later.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 9 months is below that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 2, 2026
First posted
Mar 12, 2026
StartEst.
Mar 2026
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Mar 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07466069
Responsible party
Bruno Gualano (Professor, University of Sao Paulo) — Principal investigator
First posted
Mar 12, 2026
Start date
Mar 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Mar 12, 2026

Study contacts

Bruno Gualano, PhD
Contact
gualano@usp.br
+551130618789
Bruna Caruso Mazzolani, PhD
Contact
bruna.mazzolani@usp.br

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion